278 related articles for article (PubMed ID: 30715621)
1. Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw.
Zandi M; Dehghan A; Amini P; Doulati S; Rezaeian L
Clin Oral Investig; 2019 Nov; 23(11):3987-3993. PubMed ID: 30715621
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of mandibular fracture healing in rats under zoledronate therapy: A histologic study.
Zandi M; Dehghan A; Amini P; Rezaeian L; Doulati S
Injury; 2017 Dec; 48(12):2683-2687. PubMed ID: 29042034
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Osteonecrosis of the Jaw.
Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S
J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825
[TBL] [Abstract][Full Text] [Related]
4. Histological assessment of the effects of teriparatide therapy on mandibular fracture healing: A preclinical study.
Zandi M; Dehghan A; Bigonah N; Doulati S; Mohammad Gholi Mezerji N
J Craniomaxillofac Surg; 2020 Mar; 48(3):211-216. PubMed ID: 32014386
[TBL] [Abstract][Full Text] [Related]
5. Short-term perioperative teriparatide therapy for the prevention of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats.
Zandi M; Dehghan A; Mohammadi-Mofrad A; Amini P; Vahdatinia F
J Craniomaxillofac Surg; 2017 Feb; 45(2):275-280. PubMed ID: 28087282
[TBL] [Abstract][Full Text] [Related]
6. Effect of different doses and durations of teriparatide therapy on resolution of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats.
Zandi M; Dehghan A; Zandipoor N; Amini P; Doulati S
J Craniomaxillofac Surg; 2018 Mar; 46(3):466-472. PubMed ID: 29395991
[TBL] [Abstract][Full Text] [Related]
7. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.
Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S
J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490
[TBL] [Abstract][Full Text] [Related]
8. Management of medication-related osteonecrosis of jaw: Comparison between icariin and teriparatide in a rat model.
Liu J; Mattheos N; Deng C; Su C; Wang Z; Luo N; Tang H
J Periodontol; 2021 Jan; 92(1):149-158. PubMed ID: 32281098
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model.
Tsubouchi Y; Ikeda S; Kataoka M; Tsumura H
J Orthop Surg Res; 2018 Oct; 13(1):267. PubMed ID: 30359257
[TBL] [Abstract][Full Text] [Related]
10. A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
Ohbayashi Y; Iwasaki A; Nakai F; Mashiba T; Miyake M
Osteoporos Int; 2020 Mar; 31(3):577-585. PubMed ID: 31768589
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of teriparatide effect on healing of autografted mandibular defects in rats.
Zandi M; Dehghan A; Gheysari F; Rezaeian L; Mohammad Gholi Mezerji N
J Craniomaxillofac Surg; 2019 Jan; 47(1):120-126. PubMed ID: 30528562
[TBL] [Abstract][Full Text] [Related]
12. Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.
Sim IW; Borromeo GL; Tsao C; Hardiman R; Hofman MS; Papatziamos Hjelle C; Siddique M; Cook GJR; Seymour JF; Ebeling PR
J Clin Oncol; 2020 Sep; 38(26):2971-2980. PubMed ID: 32614699
[TBL] [Abstract][Full Text] [Related]
13. Teriparatide for the Treatment of Medication-Related Osteonecrosis of the Jaw.
Chopra K; Malhan N
Am J Ther; 2020 Jun; 28(4):e469-e477. PubMed ID: 32618592
[TBL] [Abstract][Full Text] [Related]
14. Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats.
Rowshan HH; Parham MA; Baur DA; McEntee RD; Cauley E; Carriere DT; Wood JC; Demsar WJ; Pizarro JM
J Oral Maxillofac Surg; 2010 Feb; 68(2):260-7. PubMed ID: 20116693
[TBL] [Abstract][Full Text] [Related]
15. Effective ancillary role and long-term course of daily or weekly teriparatide treatment on refractory medication-related osteonecrosis of the jaw: a clinical case series.
Yoshiga D; Yoshioka I; Habu M; Sasaguri M; Tominaga K
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):604-609. PubMed ID: 34996629
[TBL] [Abstract][Full Text] [Related]
16. Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study.
Jamalpour MR; Shahabi S; Baghestani M; Shokri A; Jamshidi S; Khazaei S
BMC Oral Health; 2022 Jun; 22(1):241. PubMed ID: 35717177
[TBL] [Abstract][Full Text] [Related]
17. Use of teriparatide in osteoporotic fracture patients.
Collinge C; Favela J
Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
[TBL] [Abstract][Full Text] [Related]
18. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
[TBL] [Abstract][Full Text] [Related]
19. Short-Term Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study.
Jung J; Yoo HY; Kim GT; Lee JW; Lee YA; Kim DY; Kwon YD
J Bone Miner Res; 2017 Dec; 32(12):2445-2452. PubMed ID: 28815779
[TBL] [Abstract][Full Text] [Related]
20. Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial.
Bhandari M; Jin L; See K; Burge R; Gilchrist N; Witvrouw R; Krohn KD; Warner MR; Ahmad QI; Mitlak B
Clin Orthop Relat Res; 2016 May; 474(5):1234-44. PubMed ID: 26932738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
